97 related articles for article (PubMed ID: 11208263)
21. Ensuring quality of in vitro alternative test methods: issues and answers.
Gupta K; Rispin A; Stitzel K; Coecke S; Harbell J
Regul Toxicol Pharmacol; 2005 Dec; 43(3):219-24. PubMed ID: 16099570
[TBL] [Abstract][Full Text] [Related]
22. Three Rs potential in the development and quality control of immunobiologicals.
Halder M
ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
[TBL] [Abstract][Full Text] [Related]
23. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
[TBL] [Abstract][Full Text] [Related]
24. Eye Irritation Testing: The Way Forward. The Report and Recommendations of ECVAM Workshop 34.
Balls M; Berg N; Bruner LH; Curren RD; de Silva O; Earl LK; Esdaile DJ; Fentem JH; Liebsch M; Ohno Y; Prinsen MK; Spielmann H; Worth AP
Altern Lab Anim; 1999; 27(1):53-77. PubMed ID: 25423402
[TBL] [Abstract][Full Text] [Related]
25. Alternatives to animal experimentation: the regulatory background.
Garthoff B
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):388-92. PubMed ID: 15982684
[TBL] [Abstract][Full Text] [Related]
26. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
27. Recommendations of the ECVAM Workshop on "Alternatives to Animal Testing in the Quality Control of Immunobiologicals; State of the Art and Future Prospects".
Hendriksen CF
ALTEX; 1994; 11(5):19-20. PubMed ID: 11178401
[TBL] [Abstract][Full Text] [Related]
28. OECD test strategies and methods for endocrine disruptors.
Gelbke HP; Kayser M; Poole A
Toxicology; 2004 Dec; 205(1-2):17-25. PubMed ID: 15458786
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
30. Validation and regulatory acceptance of new carcinogenicity tests.
Spielmann H
Toxicol Pathol; 2003; 31(1):54-9. PubMed ID: 12597449
[TBL] [Abstract][Full Text] [Related]
31. The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test.
Spielmann H; Balls M; Dupuis J; Pape WJ; Pechovitch G; de Silva O; Holzhütter HG; Clothier R; Desolle P; Gerberick F; Liebsch M; Lovell WW; Maurer T; Pfannenbecker U; Potthast JM; Csato M; Sladowski D; Steiling W; Brantom P
Toxicol In Vitro; 1998 Jun; 12(3):305-27. PubMed ID: 20654413
[TBL] [Abstract][Full Text] [Related]
32. Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.
Becker RA; Borgert CJ; Webb S; Ansell J; Amundson S; Portier CJ; Goldberg A; Bruner LH; Rowan A; Curren RD; Stott WT
Regul Toxicol Pharmacol; 2006 Oct; 46(1):18-22. PubMed ID: 16876299
[TBL] [Abstract][Full Text] [Related]
33. The enhancement of the subacute repeat dose toxicity test OECD TG 407 for the detection of endocrine active chemicals: comparison with toxicity tests of longer duration.
Gelbke HP; Hofmann A; Owens JW; Freyberger A
Arch Toxicol; 2007 Apr; 81(4):227-50. PubMed ID: 17047927
[TBL] [Abstract][Full Text] [Related]
34. A chair on alternatives?
Spielmann H
ALTEX; 2002; 19(2):69-73. PubMed ID: 12098012
[TBL] [Abstract][Full Text] [Related]
35. Regulatory acceptance and use of the Extended One Generation Reproductive Toxicity Study within Europe.
Schiffelers MJ; Blaauboer BJ; Bakker WE; Hendriksen CF; Krul C
Regul Toxicol Pharmacol; 2015 Feb; 71(1):114-24. PubMed ID: 25445002
[TBL] [Abstract][Full Text] [Related]
36. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
37. Peer review of validation studies: an assessment of the role of the OECD by reference to the validation of the uterotrophic assay for endocrine disruptors.
Combes RD
Altern Lab Anim; 2004 Jun; 32(2):111-7. PubMed ID: 15601239
[TBL] [Abstract][Full Text] [Related]
38. Comments on the scientific validation and regulatory acceptance of in vitro toxicity tests.
Balls M; Clothier RH
Toxicol In Vitro; 1991; 5(5-6):535-8. PubMed ID: 20732072
[TBL] [Abstract][Full Text] [Related]
39. Validation in Support of Internationally Harmonised OECD Test Guidelines for Assessing the Safety of Chemicals.
Gourmelon A; Delrue N
Adv Exp Med Biol; 2016; 856():9-32. PubMed ID: 27671718
[TBL] [Abstract][Full Text] [Related]
40. The Production of Polyclonal Antibodies in Laboratory Animals. The Report and Recommendations of ECVAM Workshop 35.
Leenaars PP; Hendriksen CF; de Leeuw WA; Carat F; Delahaut P; Fischer R; Halder M; Hanly WC; Hartinger J; Hau J; Lindblad EB; Nicklas W; Outschoorn IM; Stewart-Tull DE
Altern Lab Anim; 1999; 27(1):79-102. PubMed ID: 25423403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
